

![]() |
The choice of the noninferiority margin in clinical trials was driven by baseline risk, type of primary outcome, and benefits of new treatment |
|
Authors | ||
Published in | Journal of Clinical Epidemiology. 2015, vol. 68, no. 10, p. 1144-1151 | |
Abstract | To explore characteristics of clinical trials that influence the choice of the noninferiority margin (NIM) when planning the trial. | |
Keywords | Adult — Confidence Intervals — Cross-Sectional Studies — Female — Humans — Male — Middle Aged — Models, Statistical — Randomized Controlled Trials as Topic — Research Personnel/psychology — Sample Size — Surveys and Questionnaires — Treatment Outcome | |
Identifiers | PMID: 25716902 | |
Full text | ||
Structures | ||
Research group | Epidémiologie clinique (115) | |
Citation (ISO format) | GAYET-AGERON, Angèle et al. The choice of the noninferiority margin in clinical trials was driven by baseline risk, type of primary outcome, and benefits of new treatment. In: Journal of Clinical Epidemiology, 2015, vol. 68, n° 10, p. 1144-1151. doi: 10.1016/j.jclinepi.2015.01.017 https://archive-ouverte.unige.ch/unige:90339 |